167 related articles for article (PubMed ID: 22405101)
1. Morphometric characteristics of basal cell carcinoma peritumoral stroma varies among basal cell carcinoma subtypes.
Lesack K; Naugler C
BMC Dermatol; 2012 Mar; 12():1. PubMed ID: 22405101
[TBL] [Abstract][Full Text] [Related]
2. Basal cell carcinoma progression correlates with host immune response and stromal alterations: a histologic analysis.
Kaur P; Mulvaney M; Carlson JA
Am J Dermatopathol; 2006 Aug; 28(4):293-307. PubMed ID: 16871032
[TBL] [Abstract][Full Text] [Related]
3. Peritumoral Clefting and Expression of MMP-2 and MMP-9 in Basal Cell Carcinoma of the Skin.
Manola I; Mataic A; Drvar DL; Pezelj I; Dzombeta TR; Kruslin B
In Vivo; 2020; 34(3):1271-1275. PubMed ID: 32354918
[TBL] [Abstract][Full Text] [Related]
4. Peritumoral matrilin-2 staining may be useful in distinguishing basal cell carcinoma from folliculocentric basaloid proliferation.
Wang Z; Lee J; Breen C; Ruenger T; Xiong F; Goreshi R; Lu M; Iwamoto S
J Cutan Pathol; 2022 Jun; 49(6):543-548. PubMed ID: 35274748
[TBL] [Abstract][Full Text] [Related]
5. Infrastructure of the telocytes from tumor stroma in the skin basal and squamous cell carcinomas.
Mirancea N; Moroşanu AM; Mirancea GV; Juravle FD; Mănoiu VS
Rom J Morphol Embryol; 2013; 54(4):1025-37. PubMed ID: 24398998
[TBL] [Abstract][Full Text] [Related]
6. Syndecan-1 expression is decreased with increasing aggressiveness of basal cell carcinoma.
Bayer-Garner IB; Dilday B; Sanderson RD; Smoller BR
Am J Dermatopathol; 2000 Apr; 22(2):119-22. PubMed ID: 10770430
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical Expression of Calponin in Cutaneous Basal Cell Carcinoma.
Bartoš V; Kullová M
Acta Dermatovenerol Croat; 2015; 23(4):254-9. PubMed ID: 26724876
[TBL] [Abstract][Full Text] [Related]
8. Host immune responses and peritumoral stromal reactions in different basal cell carcinoma subtypes: histopathological comparison of basosquamous carcinoma and high-risk and low-risk basal cell carcinoma subtypes.
Duman N; Şen Korkmaz N; Erol Z
Turk J Med Sci; 2016 Jan; 46(1):28-34. PubMed ID: 27511329
[TBL] [Abstract][Full Text] [Related]
9. Micronodular basal cell carcinoma: a distinct subtype? Relationship with nodular and infiltrative basal cell carcinomas.
Betti R; Menni S; Radaelli G; Bombonato C; Crosti C
J Dermatol; 2010 Jul; 37(7):611-6. PubMed ID: 20629826
[TBL] [Abstract][Full Text] [Related]
10. Expression of p16 Protein in Cutaneous Basal Cell Carcinoma: Still far from Being Clearly Understood.
Bartoš V
Acta Dermatovenerol Croat; 2020 Jul; 28(1):43-44. PubMed ID: 32650852
[TBL] [Abstract][Full Text] [Related]
11. An unusual infiltrative basal cell carcinoma with osteoclastic stromal changes mimicking carcinosarcoma: a case report.
Gamsizkan M; Naujokas A; Simsek HA; McCalmont TH
Am J Dermatopathol; 2015 Jan; 37(1):26-30. PubMed ID: 24786580
[TBL] [Abstract][Full Text] [Related]
12. Probing tumor and peritumoral tissues in superficial and nodular basal cell carcinoma using polarized Raman microspectroscopy.
Ly E; Durlach A; Antonicelli F; Bernard P; Manfait M; Piot O
Exp Dermatol; 2010 Jan; 19(1):68-73. PubMed ID: 19845756
[TBL] [Abstract][Full Text] [Related]
13. Basal cell carcinoma characteristics as predictors of depth of invasion.
Welsch MJ; Troiani BM; Hale L; DelTondo J; Helm KF; Clarke LE
J Am Acad Dermatol; 2012 Jul; 67(1):47-53. PubMed ID: 22507669
[TBL] [Abstract][Full Text] [Related]
14. Expression of stem cell factor in basal cell carcinoma.
Yamamoto T; Katayama I; Nishioka K
Br J Dermatol; 1997 Nov; 137(5):709-13. PubMed ID: 9415229
[TBL] [Abstract][Full Text] [Related]
15. Myofibroblast stroma differentiation in infiltrative basal cell carcinoma is accompanied by regulatory T-cells.
Ressler JM; Zila N; Korosec A; Yu J; Silmbrod R; Bachmayr V; Tittes J; Strobl J; Lichtenberger BM; Hoeller C; Petzelbauer P
J Cutan Pathol; 2023 Jun; 50(6):544-551. PubMed ID: 36562598
[TBL] [Abstract][Full Text] [Related]
16. Efficacy, rate of tumor response, and safety of a short course (12-24 weeks) of oral vismodegib in various histologic subtypes (infiltrative, nodular, and superficial) of high-risk or locally advanced basal cell carcinoma, in an open-label, prospective case series clinical trial.
Fosko SW; Chu MB; Armbrecht E; Galperin T; Potts GA; Mattox A; Kurta A; Polito K; Slutsky JB; Burkemper NM; Hurley MY
J Am Acad Dermatol; 2020 Apr; 82(4):946-954. PubMed ID: 31836564
[TBL] [Abstract][Full Text] [Related]
17. Investigation of P120catenin Expression in Human Basal Cell Carcinoma of the Skin.
Bartoš V; Kullová M
Acta Medica (Hradec Kralove); 2017; 60(1):32-36. PubMed ID: 28591550
[TBL] [Abstract][Full Text] [Related]
18. alpha vbeta 6 Integrin promotes the invasion of morphoeic basal cell carcinoma through stromal modulation.
Marsh D; Dickinson S; Neill GW; Marshall JF; Hart IR; Thomas GJ
Cancer Res; 2008 May; 68(9):3295-303. PubMed ID: 18451156
[TBL] [Abstract][Full Text] [Related]
19. Mast cells and dendritic cells in basal cell carcinoma stroma.
Humphreys TR; Monteiro MR; Murphy GF
Dermatol Surg; 2000 Mar; 26(3):200-3; discussion 203-4. PubMed ID: 10759793
[TBL] [Abstract][Full Text] [Related]
20. The stromal reaction in basal cell carcinomas. A prerequisite for tumour progression and treatment strategy.
Bertheim U; Hofer PA; Engström-Laurent A; Hellström S
Br J Plast Surg; 2004 Jul; 57(5):429-39. PubMed ID: 15191824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
